spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  SV Life Sciences 

 HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 7 Jan 2016
Alector Announces Closing of Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 2 Dec 2015
Kesios Therapeutics Raises £19 Million in Series A Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 8 Sep 2015
Lombard Medical Names David Milne to Board of Directors
Devices Interventional Personnel
 HSMN NewsFeed - 3 Sep 2015
Atopix Therapeutics Appoints Dr Andrew Zambanini as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2015
Lombard Medical Acquires Endovascular Stent Graft Developer Altura Medical
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 22 Jul 2015
KalVista Pharmaceuticals Raises $33 Million to Advance Development of Novel Plasma Kallikrein Inhibitors in Diabetic Macular Edema and Hereditary Angioedema
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Dec 2014
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 15 Nov 2013
Catabasis Closes $32.4 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Oct 2013
CardioKinetix Announces First Heart Failure Patients Treated in China With Novel Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2013
Arsanis Inc Closes $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Aug 2013
CardioKinetix Announces First Heart Failure Patients Treated in Asia with Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 29 May 2013
Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista(TM) Anti-PDGF Combination Therapy in Wet AMD
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 16 Apr 2013
CardioFocus Expands Management Team to Support Global Growth and Adoption of HeartLight(R) System
Devices Cardiology Personnel
 HSMN NewsFeed - 28 Jan 2013
Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension
Devices Drug Delivery Ophthalmology Venture Capital
 HSMN NewsFeed - 24 Oct 2012
CardioKinetix Announces Data From Latest European Study of Heart Failure Patients With First-of-Its-Kind Percutaneous Treatment
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
CardioKinetix Receives CE Mark Approval for Full Range of Sizes for First-of-Its-Kind Percutaneous Treatment for Heart Failure
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 17 Oct 2012
SV Life Sciences and Third Rock Ventures Launch Transformative Medical Device Company Cibiem with $10 Million Series A
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 7 Jun 2012
CardioKinetix Initiates European Post-Market Trial of First-of-Its-Kind Minimally Invasive Treatment for Heart Failure in Germany
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2012
CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2012
Sutro Closes $16.5 Million Second Tranche of Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 May 2012
CardioKinetix Announces Late Breaking EuroPCR Session Featuring First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2012
Maria Sainz Joins CardioKinetix as President and Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 26 Apr 2012
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2012
Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Diganostics Venture Capital Personnel
 HSMN NewsFeed - 2 Apr 2012
AlloCure Raises $25 Million Series B Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Dec 2011
Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing
Biopharmaceuticalas Venture Capital
 HSMN NewsFeed - 20 Sep 2011
CardioKinetix Inc. Raises $44 Million in Series E Financing
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 19 Sep 2011
Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 7 Jun 2011
Cyterix Pharmaceuticals Raises $9.2 Million in a Series A Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Feb 2011
CardioFocus, Inc. Raises $30.6 Million in Private Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 28 Feb 2011
Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Feb 2011
Ocular Therapeutix, Inc. Completes Series D Financing to Support Phase II Sustained Drug Delivery Clinical Trials
Devices Drug Delivery Ophthalmology Venture Capital
 HSMN NewsFeed - 8 Dec 2010
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Nov 2010
Boston Scientific to Acquire Sadra Medical
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 17 Nov 2010
Sutro Biopharma Secures $36.5 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Nov 2010
Delenex Therapeutics Secures CHF 13.5 Million Series A Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Oct 2010
New Leaf Venture Partners Invests in $35.4 (£22.4) Million Series A Financing of Convergence Pharmaceuticals
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jul 2010
AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 1 Jul 2010
Lux Biosciences Names Dean Mitchell President and CEO
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 29 Jun 2010
AqueSys, Inc. Closes $35M Series C Round
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 1 Jun 2010
Altura Medical Completes $20 Million Round of Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 May 2010
Logical Therapeutics Secures $16.9M Series C Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Apr 2010
SV Life Sciences Adds Health Care Services Veteran Paul Wallace as Venture Partner
Biopharmaceuticals Devices Venture Capital Personnel
 HSMN NewsFeed - 8 Mar 2010
EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2010
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Dec 2009
Ophthotech Raises $30 Million in Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 24 Nov 2009
Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 Nov 2009
Entellus Medical(R) Secures $30 Million Financing To Expand Commercialization of Novel Treatments for Sinusitis
Devices Venture Capital
 HSMN NewsFeed - 19 Oct 2009
Lux Biosciences Completes $50 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 8 Oct 2009
Transenterix Secures $55 Million in Financing
Devices Surgery Venture Capital
 HSMN NewsFeed - 1 Oct 2009
Ocular Therapeutix, Inc. Appoints Two New Board Members
Devices Ophthalmology Personnel
 HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Sep 2009
ValenTx Completes $22 Million Series B Preferred Stock Financing
Devices Venture Capital
 HSMN NewsFeed - 19 Jun 2009
I-Therapeutix, Inc. Closes $15 Million Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 11 May 2009
Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2009
Sadra Medical Raises $30 Million
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 21 Apr 2009
Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2009
EUSA Pharma Completes the European Launch of CAPHOSOL(R) for Prevention and Treatment of Oral Mucositis Caused by Cancer Therapy
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2009
Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Nov 2008
Adimab, Inc. Announces Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Sep 2008
Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Aug 2008
ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jun 2008
Itero Biopharmaceuticals Inks Partnership With Indian Biotechnology Firm, Biological E.; Raises $21 Million Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 May 2008
EUSA Pharma Completes Acquisition Of Cytogen Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Apr 2008
Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2008
CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 11 Mar 2008
EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Jan 2008
Biogen Idec and PDL BioPharma License the Rights to Develop Volociximab in Ophthalmic Indications to Ophthotech
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 8 Jan 2008
SV Life Sciences Appoints Dr. Hamish Cameron as Venture Partner
Venture Capital Personnel
 HSMN NewsFeed - 10 Dec 2007
Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Nov 2007
SV Life Sciences Adds Medical Device Executive to MedTech Team
Venture Capital
 HSMN NewsFeed - 6 Sep 2007
Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Biopharmaceuticals Surgery Acquisitions
 HSMN NewsFeed - 5 Sep 2007
NeurogesX Appoints New Director to the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2007
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 11 Jul 2007
Sadra Medical Announces Successful Clinical Use of the First Retrievable, Repositionable Transcatheter Aortic Heart Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jun 2007
Logical Therapeutics Inc. Raises US $30M Series B to Advance Drug Pipeline Targeting Inflammatory Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Mar 2007
Affinium Pharmaceuticals Closes US$18 Million Series A to Advance Clinical Development of Novel Antibacterial Compound
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Nov 2006
Neurotech(TM), Inc. Completes $35 Million Private Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Oct 2006
Sadra Medical Raises $19 Million in Series B Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 9 Oct 2006
Pfizer Expands Commitment to Fight Infectious Diseases With Agreement to Acquire Vaccine Company PowderMed Ltd
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 25 May 2006
Lux Biosciences Raises $36 Million in Series A Financing and Signs Agreement for Advanced Clinical Stage Product
Biopharmaceuticals Venture Capital Licensing
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
SV Life Sciences
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!